- Role of Placental Growth Factor in Mesenteric Neoangiogenesis in a Mouse Model of Portal Hypertension
[作者：Van Steenkiste, C; Geerts, A; Vanheule, E; Van Vlierberghe, H; De Vs, F; Olievier, K; Casteleyn, C; Laukens, D; De Vos, M; Stassen, JM; Carmeliet, P; Colle, I,期刊：Gastroenterology, 页码：2112-2124 , 文章类型： Article，,卷期：2009年137-6]
- BACKGROUND & AIMS: Portal hypertension is responsible for the major complications associated with cirrhosis. Angiogenesis has been associated with the pathophysiology of portal hypertension. We investigated the role of p...
- Long-term Probability of and Mortality From De Novo Malignancy After Liver Transplantation
[作者：Watt, KDS; Pedersen, RA; Kremers, WK; Heimbach, JK; Sanchez, W; Gores, GJ,期刊：Gastroenterology, 页码：2010-2017 , 文章类型： Article，,卷期：2009年137-6]
- BACKGROUND & AIMS: Information about malignancies that arise in patients after liver transplantation comes from volunteer registry databases and single-center retrospective studies. We analyzed a multicenter, prospective...
- Admission Volume Determines Outcome for Patients With Acute Pancreatitis
[作者：Singla, A; Simons, J; Li, YF; Csikesz, NG; Ng, SC; Tseng, JF; Shah, SA,期刊：Gastroenterology, 页码：1995-2001 , 文章类型： Article，,卷期：2009年137-6]
- BACKGROUND & AIMS: There is controversy over the optimal management strategy for patients with acute pancreatitis (AP). Studies have shown a hospital volume benefit for in-hospital mortality after surgery, and we examine...
- Protection of Epithelial Barrier Function by the Crohn's Disease Associated Gene Protein Tyrosine Phosphatase N2
[作者：Scharl, M; Paul, G; Weber, A; Jung, BC; Docherty, MJ; Hausmann, M; Rogler, G; Barrett, KE; McCole, DF,期刊：Gastroenterology, 页码：2030-2040 , 文章类型： Article，,卷期：2009年137-6]
- BACKGROUND & AIMS: Protein tyrosine phosphatase N2 (PTPN2) has been identified as a Crohn's disease (CD) candidate gene. However, a role for PTPN2 in the pathogenesis of CD has not been identified. Increased permeability...
- Factors That Predict Response of Patients With Hepatitis B e Antigen-Positive Chronic Hepatitis B to Peginterferon-Alfa
[作者：Buster, EHCJ; Hansen, BE; Lau, GKK; Piratvisuth, T; Zeuzem, S; Steyerberg, EW; Janssen, HLA,期刊：Gastroenterology, 页码：2002-2009 , 文章类型： Article，,卷期：2009年137-6]
- BACKGROUND & AIMS: Therapy with pegylated interferon (PEG-IFN)-alfa results in sustained response in a minority of patients with chronic hepatitis B virus (HBV) infection and has considerable side effects. We analyzed da...
- An Imbalance of Pro- vs Anti-Coagulation Factors in Plasma From Patients With Cirrhosis
[作者：Tripodi, A; Primignani, M; Chantarangkul, V; Dell'Era, A; Clerici, M; de Franchis, R; Colombo, M; Mannucci, PM,期刊：Gastroenterology, 页码：2105-2111 , 文章类型： Article，,卷期：2009年137-6]
- BACKGROUND & AIMS: Patients with cirrhosis have an increased tendency to develop thromboses despite the longer coagulation times of their plasma, compared with that of healthy individuals. We investigated whether plasma ...
- Effect of HCV RNA Suppression During Peginterferon Alfa-2a Maintenance Therapy on Clinical Outcomes in the HALT-C Trial
[作者：Shiffman, ML; Morishima, C; Dienstag, JL; Lindsay, KL; Hoefs, JC; Lee, WM; Wright, EC; Naishadham, D; Everson, GT; Lok, AS; Di Bisceglie, AM; Bonkovsky, HL; Ghany, MG,期刊：Gastroenterology, 页码：1986-1994 , 文章类型： Article，,卷期：2009年137-6]
- BACKGROUND & AIMS: The Hepatitis C Antiviral Long-term Treatment Against Cirrhosis (HALT-C) trial demonstrated that low-dose peginterferon maintenance therapy was ineffective in preventing clinical outcomes in patients w...
|